Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women

Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women

A pivotal study in women aged 16–26 years demonstrated that the nine-valent human papillomavirus (9vHPV) vaccine was efficacious against high-grade cervical dysplasia related to the HPV types covered by the vaccine. To evaluate whether effectiveness remains above 90% for up to 14 years post-vaccinat...

Full description

Saved in:
Bibliographic Details
Main Authors: Susanne K. Kjaer, Thea E. Hetland Falkenthal, Karin Sundström, Christian Munk, Tina Sture, Oliver Bautista, Sonali Rawat, Alain Luxembourg
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Cervical intraepithelial neoplasia
effectiveness
human papillomavirus
long-term follow-up
vaccine
nine-valent human papillomavirus vaccine
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2377903
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items